Home

Publications

Export 21 results:
Journal Article
  1. [LEPO-13b] B. Leporq, H. Ratiney, F. Pilleul, and O. Beuf, "Liver fat volume fraction quantification with fat and water T1 and T2* estimation and accounting for NMR multiple components in patients with chronic liver disease at 1.5 and 3.0 T", European Radiology, In Press .
  2. [LEPO-13a] B. Leporq, S. Camarasu-Pop, E. E. Dávila-Serrano, F. Pilleul, and O. Beuf, "Enabling 3D-Liver Perfusion Mapping from MR-DCE Imaging Using Distributed Computing", Journal of Medical Engineering, vol. 2013, 2013 .
  3. [LEPO-12a] B. Leporq, J. Dumortier, F. Pilleul, and O. Beuf, "3D-liver perfusion MRI with the MS-325 blood pool agent: A noninvasive protocol to asses liver fibrosis.", J Magn Reson Imaging, vol. 35, no. 6, 2012 .
  4. [LEPO-11a] B. Leporq, O. Beuf, and F. Pilleul, "IRM de perfusion hépatique avec un agent de contraste à rémanence vasculaire", J Radiol, vol. 92, no. 3, pp. 257-261, Mar, 2011.
Conference Paper
  1. [LEPO-13g] B. Leporq, A. Le Troter, Y. Le Fur, E. Salort-Campana, P. J. Cozzone, O. Beuf, and D. Bendahan, "Combination of a fat volume fraction quantification method with a dedicated automatic segmentation algorithm for simultaneous measurement of infiltrated fatty tissue fraction and muscle relaxation times", 21th Annual meeting of the ISMRM, Salt Lake City, USA, pp. 4040, April 2013.
  2. [LEPO-13c] B. Leporq, F. Pilleul, J. Dumortier, O. Guillaud, T. Lefort, P. J. Valette, and O. Beuf, "Combination of liver intravoxel incoherent motion imaging with MR fat quantification at 3.0T to distinguish between pure steatosis and NASH", European Congress of Radiology, Vienna, Austria, march 2013.
  3. [LEPO-13f] B. Leporq, F. Pilleul, J. Dumortier, O. Guillaud, M. Lefort, and O. Beuf, "Distinction between pure steatosis and NASH using a fat quantification method in combination with liver intravoxel incoherent motion imaging in MRI at 3.0 T", 21th Annual meeting of the ISMRM, Salt Lake City, USA, pp. 3880, April 2013.
  4. [LEPO-13d] B. Leporq, F. Pilleul, and O. Beuf, "Liver fat volume fraction quantification in patients with chronic liver diseases with separated estimation of fat and water relaxation times at 1.5 and 3.0T", European Congress of Radiology, Vienna, Austria, march 2013.
  5. [LEPO-13e] B. Leporq, F. Pilleul, J. Dumortier, O. Guillaud, M. Lefort, and O. Beuf, "Liver perfusion quantification with MR-DCE imaging at 3.0 T for liver fibrosis assessment in patients with chronic liver diseases", 21th Annual meeting of the ISMRM, Salt Lake City, USA, pp. 3911, April 2013.
  6. [LEPO-12d] B. Leporq, F. Pilleul, and O. Beuf, "Liver intravoxel incoherent motion imaging at 3.0T: comparison with conventional dual b-values method", European Congress of Radiology, Vienna, Austria, 03/2012.
  7. [LEPO-12c] B. Leporq, H. Ratiney, H. Saint Jalmes, F. Pilleul, and O. Beuf, "MR-liver fat volume fraction quantification using a magnitude-based technique with independent fat and water T2* estimations, T1-related bias correction and accounting for fat multiple resonances", 20th Scientific meeting of the ISMRM, Melbourne, Australia, 05/2012.
  8. [LEPO-12b] B. Leporq, H. Ratiney, F. Pilleul, and O. Beuf, "MR-liver steatosis assessment using a magnitude-based technique with independent fat and water T2* estimations, T1-related bias correction and accounting for spectral complexity of fat", Congrès inaugural de la Société Française de Résonance Magnétique en Biologie et Médecine (SFRMBM), Marseille, 03/2012.
  9. [LEPO-12e] B. Leporq, F. Pilleul, and O. Beuf, "Optimization of liver intravoxel incoherent motion imaging protocol at 3.0T for chronic liver diseases assessment", European Congress of Radiology, 03/2012.
  10. [LEPO-11d] B. Leporq, S. Caramasu-Pop, F. Pilleul, and O. Beuf, "3D-liver MR-DCE imaging for quantitative perfusion mapping using EGI grid", Colloque Recherche en Imagerie et Technologies pour la Santé (RITS), Rennes, France, 6-8 Avril, 2011.
  11. [LEPO-11c] B. Leporq, S. Camarasu-Pop, F. Pilleul, and O. Beuf, "3D-liver quantitative perfusion mapping using EGEE grid with MR-DCE imaging and MS-325 blood pool contrast agent", ISMRM, Montreal, Canada, pp. 2046, May, 2011.
  12. [LEPO-11b] B. Leporq, O. Beuf, D. Grenier, and F. Pilleul, "Liver intravoxel incoherent motion imaging at 3.0T with eDWI sequence - preliminary experience", European Society for Magnetic Resnonace in Medicine and Biology, Leipzig, MAGMA, October 6, 2011.
  13. [LEPO-10b] B. Leporq, O. Beuf, D. Grenier, and F. Pilleul, "3D-liver perfusion MR imaging with MS-325 blood pool contrast agent to evaluate liver fibrosis", ISMRM-ESMRMB Joint Annual Meeting, Stockholm, Sweden, 1-7 May, 2010.
  14. [LEPO-10c] B. Leporq, O. Beuf, and F. Pilleul, "3D-liver MR perfusion imaging with the MS-325 blood pool agent to assess liver Fibrosis", European Congress of Radiology, Vienna, Austria, pp. 533, 4-8 March, 2010.
  15. [LEPO-10a] B. Leporq, H. Ratiney, S. Cavassila, F. Pilleul, and O. Beuf, "Fat content quantification errors using multiple gradient echo imaging: A phantom and simulation study", ISMRM-ESMRMB Joint Annual Meeting, Stockholm, Sweden, 1-7 May, 2010.
  16. [LEPO-09a] B. Leporq, F. Pilleul, and O. Beuf, "3D liver perfusion MR-imaging with a blood pool agent: methodological aspect", ESMRMB, Antalya,Turkey, pp. 521, 2009.
  17. [LEPO-09b] B. Leporq, O. Beuf, and F. Pilleul, "Liver perfusion MR imaging: A non invasive method to assess liver fibrosis", ESMRMB, Antalya,Turkey, pp. 112, 2009.